Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Microbes and Infection|June 6, 2003
The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformansJudith N Steenbergen, Arturo CasadevallMedical Mycology|May 6, 2004
Cryptococcus neoformans var. gattii can exploit Acanthamoeba castellanii for growthStephanie D Malliaris, Judith N Steenbergen, Arturo CasadevallCurrent Opinion in Microbiology|August 28, 2003
'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi--the Cryptococcus neoformans paradigmArturo Casadevall, Judith N Steenbergen, Joshua D NosanchukThe Journal of Antimicrobial Chemotherapy|October 15, 2009
Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studiesJudith N Steenbergen, John F Mohr, Grace M ThorneAntimicrobial Agents and Chemotherapy|May 20, 2009
Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilmPhilip S Stewart, William M Davison, Judith N SteenbergenThe Lancet. Infectious Diseases|September 26, 2009
Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptionsPamela A Moise, Donald North, Judith N Steenbergen, et al.Infection and Immunity|August 23, 2003
Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideumJudith N Steenbergen, Joshua D Nosanchuk, Stephanie D Malliaris, et al.Infection and Immunity|May 25, 2004
Interaction of Blastomyces dermatitidis, Sporothrix schenckii, and Histoplasma capsulatum with Acanthamoeba castellaniiJudith N Steenbergen, Joshua D Nosanchuk, Stephanie D Malliaris, et al.Antimicrobial Agents and Chemotherapy|November 11, 2015
In Vitro Activity of Ceftolozane-Tazobactam against Anaerobic Organisms Identified during the ASPECT-cIAI StudyEliana S Armstrong, David J Farrell, Melissa Palchak, et al.The Journal of Antimicrobial Chemotherapy|February 12, 2005
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infectionsJudith N Steenbergen, Jeff Alder, Grace M Thorne, et al.Pageof 4